Clinical Trial: Liver Transplant CGM

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216508) titled 'Liver Transplant CGM' on Oct. 09.

Brief Summary: This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Study Start Date: Oct., 2025

Study Type: OBSERVATIONAL

Condition: Liver Transplant Post Transplant Diabetes Type 2 Diabetes

Intervention: DEVICE: Libre 3+

Blinded CGM will be worn by all participants

Recruitment Status: RECRUITING

Sponsor: Icahn School of Medicine at Mount Sinai

Information provided by (Responsible Party): Grenye O'Malley, Icahn School o...